Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Carducci

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Cancer|June 28, 2000
Identification and characterization of circulating prostate carcinoma cellsZ P Wang, M A Eisenberger, M A Carducci, et al.
Cytometry|June 17, 1998
Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancerC G Healy, J W Simons, M A Carducci, et al.
Urology|January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinomaM A Carducci, S Piantadosi, C R Pound, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2015
Serial blood-based analysis of AR-V7 in men with advanced prostate cancerM Nakazawa, C Lu, Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignanciesJ Gilbert, S D Baker, M K Bowling, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1996
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomyM A Carducci, R A Abrams, C J Yeo, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2013
Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancerM T Schweizer, J Lin, A Blackford, et al.
Prostate Cancer and Prostatic Diseases|October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancerC J Paller, D Olatoye, S Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion scheduleM A Carducci, J Gilbert, M K Bowling, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Cancer|June 28, 2000
Identification and characterization of circulating prostate carcinoma cellsZ P Wang, M A Eisenberger, M A Carducci, et al.
Cytometry|June 17, 1998
Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancerC G Healy, J W Simons, M A Carducci, et al.
Urology|January 14, 1999
Nuclear morphometry adds significant prognostic information to stage and grade for renal cell carcinomaM A Carducci, S Piantadosi, C R Pound, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 29, 2015
Serial blood-based analysis of AR-V7 in men with advanced prostate cancerM Nakazawa, C Lu, Y Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignanciesJ Gilbert, S D Baker, M K Bowling, et al.
International Journal of Radiation Oncology, Biology, Physics|April 1, 1996
Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomyM A Carducci, R A Abrams, C J Yeo, et al.
Prostate Cancer and Prostatic Diseases|August 21, 2013
Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancerM T Schweizer, J Lin, A Blackford, et al.
Prostate Cancer and Prostatic Diseases|October 9, 2013
The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancerC J Paller, D Olatoye, S Xie, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1996
Phenylbutyrate induces apoptosis in human prostate cancer and is more potent than phenylacetateM A Carducci, J B Nelson, K M Chan-Tack, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2001
A Phase I clinical and pharmacological evaluation of sodium phenylbutyrate on an 120-h infusion scheduleM A Carducci, J Gilbert, M K Bowling, et al.
Pageof 5